ABBV

AbbVie
ABBV

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$337.52B
EV
$402.41B
Shares Outstanding
1.77B
Beta
0.49

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$208.86
P/E 2025E
15.61x
P/Revenue 2025E
5.64x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About AbbVie Inc.

gainify
ABBV

AbbVie Inc.

ABBV

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disea...

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Michael, Robert

Employees

55,000

IPO Date

2013-01-02

Headquarters

1 North Waukegan Road, North Chicago, Illinois, 60064-6400, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.